MedPath

Dietary Advanced Glycation End Products and Migraine

Completed
Conditions
Nutrition Disorders
Migraine Disorders
Registration Number
NCT05747911
Lead Sponsor
Karabuk University
Brief Summary

Is dietary intake of advanced glycation different between individuals with and without migraine? Is there a difference between the groups in terms of energy and nutrients? The answers to these questions are sought.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • To be diagnosed with episodic migraine by an experienced neurologist,
  • For the control group, patients who were not diagnosed with migraine but applied to the headache outpatient clinic
  • Volunteer
Exclusion Criteria
  • Being younger than 19 years and older than 64 years of age, having a history of cardiovascular disease, hypertension, diabetes, cancer, liver and kidney disease or other neurological disorder (epilepsy, multiple sclerosis, stroke, traumatic brain injury, etc.), secondary headache, antilipidemic and glucose taking intolerance medications or vitamin-mineral supplements, following a special diet, and consuming less than 800 kcal or more than 4000 kcal per day

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference in dietary advanced glycation end products intake between groups2 months

Is there a difference between the dietary intake of advanced glycation end products in individuals with migraine and healthy individuals? These values will be obtained from the food consumption records of the individuals. Intake of advanced glycation end product will be evaluated as ....kU/day.

Is there a difference between the energy and nutrient intake of individuals with migraine and healthy individuals?

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Karabuk University

🇹🇷

Karabük, Turkey

Karabuk University
🇹🇷Karabük, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.